Anita Liao
Onderzoeker
- Naam
- C. Liao MSc
- Telefoon
- 071 5272727
- c.liao@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0001-7440-4065
Meer informatie is beschikbaar op de Engelse profielpagina.
Meer informatie is beschikbaar op de Engelse profielpagina.
Onderzoeker
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Toxicology
- Liao C., Engelberts P., Dijk M. van, Timmermans A., Martens J.W.M., Neubert E. & Danen E.H.J. (2025), CD3xHER2 bsAb-mediated activation of resting T-cells at HER2 positive tumor clusters is sufficient to trigger bystander eradication of distant HER2 negative clusters through IFNγ and TNFα, European Journal of Immunology 55(4): e202451589.
- Liao C., Hundscheid J.H.M., Crawford J., Dijke P. ten, Coornaert B. & Danen E.H.J. (2025), Novel high throughput 3D ECM remodeling assay identifies MEK as key driver of fibrotic fibroblast activity, Materials Today Bio 32: 101800.
- Coban B., Wang Z., Liao C., Beslmüller K., Timmermans M.A.M., Martens J.W.M., Hunscheid J.H.M., Slütter B.A., Zweemer A.J.M., Neubert E. & Danen E.H.J. (2024), GRHL2 suppression of NT5E/CD73 in breast cancer cells modulates CD73-mediated adenosine production and T cell recruitment, iScience 27(5): 109738.
- Liao C., Engelberts P., Ioan-Facsinay A., Klip J.A., Schmidt T., Ruijtenbeek R. & Danen E.H.J. (2024), CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing, Communications Biology 7(1): 983.
- Kortleve D., Hammerl D., Brakel M. van, Wijers R., Roelofs D., Kroese K., Timmermans M.M., Liao C., Huang S., Trapman-Jansen A., Foekens R., Michaux J., Beijer M.T.A. de, Buschow S.I., Demmers J.A.A., Kok M., Danen E.H.J., Bassani-Sternberg M., Martens J.W.M., Abbott R.J.M. & Debets R. (2024), TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer, Cancer Discovery 14(12): 2450-2470.
- Dang H., Harryvan T.J., Liao C.Y., Danen E.H.J., Spalburg V.N.L.N., Kielbasa S.M., Mei H., Goeman J.J., Jonge-Muller E.S. de, Janson S.G.T., Reijden J.J. van der, Crobach S., Hardwick J.C.H., Boonstra J.J., Miranda N.F.C.C. de & Hawinkels L.J.A.C. (2023), Cancer-associated fibroblasts are key determinants of cancer cell invasion in the earliest stage of colorectal cancer, Cellular and Molecular Gastroenterology and Hepatology 16(1): 107-131.
- Dang H., Harrijvan T.J., Liao C., Danen E.H.J., Miranda N.F. de, Hardwick J., Boonstra J. & Hawinkels L. (2022), Cancer-associated fibroblasts in T1 colorectal cancer promote matrix remodeling and tumor organoid expansion, Gastroenterology 162(7): S323.